Stay updated on Autologous LN-145 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.

Latest updates to the Autologous LN-145 in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new revision of the page’s metadata. This is a minor update to the page version and does not change the visible content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedA minor page revision/build identifier was updated from `v3.5.2` to `v3.5.3`, indicating a technical site update without altering the study information shown.SummaryDifference0.0%

- Check45 days agoChange DetectedNew study sites were added: Hospital Universitario de Salamanca (Salamanca, Spain); Fondazione IRCCS Policlinico San Matteo di Pavia (Pavia, Italy); Charite- Universitätsklinikum Berlin (Berlin, Germany); Gustave Roussy Cancer Campus (Villejuif, France); CHRU de Poitiers La Miletrie (Poitiers, France); CHU Nice (Nice, France); Banner Health MD Anderson (Gilbert, AZ). The total number of study locations is now 91.SummaryDifference0.8%

- Check73 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check109 days agoChange DetectedRevision: v3.4.2 was added. Revision: v3.4.1 was removed.SummaryDifference0.0%

Stay in the know with updates to Autologous LN-145 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.